Safety of a drug-coated balloon for heart artery blockages
Part of Heart & circulation, Pain clinical trials.
This study tests a special balloon coated with a drug called sirolimus to open blocked heart arteries. It may be an option for people with coronary artery disease who need a less invasive treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You have blockages in your heart arteries (coronary artery disease).
- You are not allergic to sirolimus or the study device.
- You can take blood thinners (antiplatelet therapy).
- You are expected to live at least 12 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new balloon coated with sirolimus (a drug that helps prevent re-blockage) for treating blocked arteries at branch points (bifurcations) in the heart. If you have a blocked artery at a branch point, this study may offer a way to treat the side branch without placing a stent there.
This study is testing a special balloon that releases a drug (sirolimus) to treat fatty plaques in heart arteries that are not yet blocking blood flow. The hope is that this treatment can stabilize or even shrink these plaques, reducing future risk of heart attacks. If you have recently had a heart attack and have other non-obstructive plaques, this trial might offer a new approach.
This trial tests a new drug-coated balloon (Genoss SCB) versus an existing one (SeQuent Please NEO) for people whose heart stents have re-narrowed. It aims to see which balloon better keeps the artery open.
This trial is testing a special balloon coated with medication to treat newly formed blockages in the heart's arteries. The medication may help keep the artery open after the balloon opens it during a standard procedure.
This trial tests how the way a drug-coated balloon is used during a heart procedure affects outcomes for people with stable heart disease or unstable angina. It may help doctors find the best technique to keep arteries open.
This study tests a balloon coated with a drug that may help keep arteries open after they've been cleared, especially for people with a narrowing inside a previously placed stent or in a small heart artery. It's a first-time-in-humans study to check if the treatment is safe and works.
Hear when a new Coronary Arterial Disease (CAD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.